Camlin Fine Sciences (CAMLINFINE) Fundamentals 2026 — P/E 88.0x, Revenue Analysis | SniperIQ
Camlin Fine Sciences (CAMLINFINE) is a India-listed Basic Materials company in Chemicals - Specialty with a market capitalization of ₹2,333 Crore, trading at ₹121.44 on the NSE. This SniperIQ fundamentals page covers Camlin Fine Sciences's valuation (P/E 88.0x, P/B 2.2x), profitability (net margin 1.6%), revenue (₹1,723 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Camlin Fine Sciences's market cap?
Camlin Fine Sciences (CAMLINFINE) has a market capitalization of approximately ₹2,333 Crore, trading at ₹121.44 on the NSE. Market cap moves with the live share price.
What is Camlin Fine Sciences's P/E ratio?
Camlin Fine Sciences's trailing twelve-month P/E ratio is 88.0x, with a price-to-book (P/B) of 2.2x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is Camlin Fine Sciences?
Camlin Fine Sciences runs a net profit margin of 1.6%, a gross margin of 36.7%, and an operating margin of 0.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Camlin Fine Sciences generate?
Camlin Fine Sciences reported revenue of ₹1,723 Crore for fiscal year 2026, with net income of ₹28 Crore and earnings per share (EPS) of 1.46. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Camlin Fine Sciences pay a dividend?
Camlin Fine Sciences does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Camlin Fine Sciences financially healthy?
Camlin Fine Sciences carries a debt-to-equity ratio of 0.69x and a current ratio of 1.27x, with a market beta of 0.64. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Camlin Fine Sciences a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Camlin Fine Sciences (CAMLINFINE) the key facts are: market cap ₹2,333 Crore, P/E 88.0x, revenue ₹1,723 Crore, 52-week range 96.21-298. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track Camlin Fine Sciences's full fundamentals live
Get Camlin Fine Sciences's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.